A comparative study of external application of Shrungaveradi Lepa and Edgajadi Lepa in 72 patients of Dadru Kushtha a skin disease known as tinea corporis
- Conditions
- Tinea corporis. Ayurveda Condition: DADRU-KUSHTHAH,
- Registration Number
- CTRI/2025/05/086266
- Lead Sponsor
- Seth RV Ayurved Hospital
- Brief Summary
The primary purpose of this open randomizedcomparative clinical study is to evaluate and compare the efficacy ofShrungaveradi Lepa and Edgajadi Lepa in the management of Dadru Kushtha - TineaCorporis, a superficial fungal infection of the skin characterized by itching-kandu, redness -raga, eruptions - pidaka, and raised patches -udgat mandala.According to Ayurveda, Dadru is classified under Kushtha and is associated withKapha and Pitta dosha imbalances, affecting the skin, blood, muscle, and lymphtissues. In contemporary understanding, Tinea Corporis is a dermatophyteinfection commonly affecting adults, especially those exposed to warm, moistconditions. The study involves a total of 72 patients, divided equally into twogroups 36 each, with a treatment duration of 21 days. Each formulation isapplied locally at a dose of 200 mg per square cm twice daily. The primaryhypothesis states that both Shrungaveradi Lepa and Edgajadi Lepa are equallyeffective, however secondary hypotheses explore whether one may be superior.The study aims to scientifically validate the traditional Ayurvedic topicaltherapy, offering a potential evidence-based alternative for managingsuperficial fungal infections.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- All
- Target Recruitment
- 72
Age 18 to 60 years Sex All genders Patient with signs and symptoms of Dadru Kushtha Tinea corporis like Kandu Raga Pidaka and udgat mandala Patient understanding and willing to sign the informed consent form Area of largest lesion 25cm square.
Patient having skin lesions other than Dadru kushtha Tinea corporis like Eczema psoriasis and urticaria Pregnancy and lactating mother Known case of AIDS HIV Positive and Hepatitis B.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Kandu – Itching Three weeks Daha - burning Three weeks Pidaka – papule Three weeks Size and Number of Lesions in specific areas of the body. Three weeks Raga - Erythema Three weeks
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Seth RV Ayurvedic Hospital
🇮🇳Mumbai, MAHARASHTRA, India
Seth RV Ayurvedic Hospital🇮🇳Mumbai, MAHARASHTRA, IndiaDr Umesh Ganeshrao GhugePrincipal investigator9881094175umeshghuge2208@gmail.com